483 DERMDOX CENTERS FOR DERMATOLOGY Jan 2021

483 DERMDOX CENTERS FOR DERMATOLOGY Jan 2021

Kelly Kerr FDA, Gabrielle Swain FDA$119.00 - Available Now

FDA investigators audited the DERMDOX CENTERS FOR DERMATOLOGY - Sugarloaf, PA, United States facility and issued inspectional observations (via FDA 483) on 21 Jan 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Jan 2021
  • Location: Sugarloaf, United States
  • FEI: 3015543263
Add To Cart